Skip to content

The effects of preventive versus on demand nutritional advice and support on the nutritional status of patients during antiviral therapy for hepatitis C

The effects of preventive versus on demand nutritional advice and support on the nutritional status of patients during antiviral therapy for hepatitis C - Peginterferon and weight loss

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31567
Enrollment
50
Registered
2008-05-27
Start date
2008-06-17
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malnutrition weight loss

Interventions

Patients in the preventive group will receive (depending on duration of therapy: 24 vs. 48 weeks) 7 to 9 consultations or preparation time according to Dutch guidelines concerning malnutrition, and

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Diagnosis of hepatitis C • Indication for antiviral treatment with peginterferon in combination with ribavirin • Not yet started with aniviral treatment • Age > 18 years • Good understanding of Dutch or English language • Informed consent

Exclusion criteria

Exclusion criteria: • Co-infection with hepatitis B and/or HIV • Significant non hepatic diseases such as decompensated heart, respiratory or renal failure • Crohns disease or colitis ulcerosa • Significant previous surgery of the gastro-intestinal tract • Hepatocellular carcinoma or other current malignant disease • BMI

Design outcomes

Primary

MeasureTime frame
Primary study parameter is weight loss.

Secondary

MeasureTime frame
Secundary study parameters are: handgrip strength creatinin-height index MAMC energy balance serum levels of markers of malnutrition. Quality of life Side effects Digestive symptoms In a subgroup: gastric emptying

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)